HOUSTON / Apr 23, 2025 / Business Wire / U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the first quarter ended March 31, 2025, on Wednesday, May 7, 2025, after the stock market closes, with the conference call to follow the next morning, on Thursday, May 8, 2025.
Conference Call Date: | Thursday, May 8, 2025 |
|
| Time: | 10:30 am Eastern /9:30 am Central |
| Dial-In Number: | (800) 274-8461 Primary or |
|
| (203) 518-9814 Alternate |
| Conference ID: | USPHQ125 |
| (In order to join this conference call, | |
you will be required to provide the Conference ID listed above) | ||
To participate, please call in 15 minutes prior to start time. | ||
To listen to the live call, please go to www.usph.com and click on conference calls under the Investor Relations section. Please go to the website 15 minutes early to register, download and install any necessary audio software. If you are unable to listen live, a playback of the conference call can be accessed until August 6, 2025, at U.S. Physical Therapy’s website.
About U.S. Physical Therapy, Inc.
Founded in 1990, U.S. Physical Therapy, Inc. owns and/or manages 773 outpatient physical therapy clinics in 44 states. USPH clinics provide preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurologically-related injuries and rehabilitation of injured workers. USPH also has an industrial injury prevention business which provides onsite services for clients’ employees including injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments.
More information about U.S. Physical Therapy, Inc. is available at www.usph.com. The information included on that website is not incorporated into this press release.
| Last Trade: | US$73.85 |
| Daily Change: | -0.09 -0.12 |
| Daily Volume: | 39,742 |
| Market Cap: | US$1.120B |
November 05, 2025 August 06, 2025 August 01, 2025 April 30, 2025 | |

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORE
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MOREEnd of content
No more pages to load